These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7570831)

  • 1. An outbreak of acute kala-azar in a nomadic tribe in western Sudan: features of the disease in a previously non-immune population.
    Hashim FA; Ali MS; Satti M; el-Hassan AM; Ghalib HW; el Safi S; el Hag IA
    Trans R Soc Trop Med Hyg; 1994; 88(4):431-2. PubMed ID: 7570831
    [No Abstract]   [Full Text] [Related]  

  • 2. Kala-azar in western Upper Nile province in the southern Sudan and its spread to a nomadic tribe from the north.
    el-Hassan AM; Hashim FA; Ali MS; Ghalib HW; Zijlstra EE
    Trans R Soc Trop Med Hyg; 1993; 87(4):395-8. PubMed ID: 8249061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings.
    Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW; Sondorp E; Winkler A
    Trans R Soc Trop Med Hyg; 1991; 85(3):365-9. PubMed ID: 1658990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sudan, through the back door].
    Veeken H
    Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1781-5. PubMed ID: 9856145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.
    el Hassan AM; Ghalib HW; Zijlstra EE; Eltoum IA; Satti M; Ali MS; Ali HM
    Trans R Soc Trop Med Hyg; 1992; 86(3):245-8. PubMed ID: 1329273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis.
    de Beer P; el Harith A; Deng LL; Semiao-Santos SJ; Chantal B; van Grootheest M
    Am J Trop Med Hyg; 1991 Mar; 44(3):283-9. PubMed ID: 1852133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral leishmaniasis (kala-azar) as a cause of fever of unknown origin.
    Geraci JE; Wilson WR; Thompson JH
    Mayo Clin Proc; 1980 Jul; 55(7):455-8. PubMed ID: 6247584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of lymph node aspiration in the diagnosis of visceral leishmaniasis in Sudan.
    Babiker ZO; Davidson R; Mazinda C; Kipngetich S; Ritmeijer K
    Am J Trop Med Hyg; 2007 Apr; 76(4):689-93. PubMed ID: 17426171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan.
    Collin S; Davidson R; Ritmeijer K; Keus K; Melaku Y; Kipngetich S; Davies C
    Clin Infect Dis; 2004 Mar; 38(5):612-9. PubMed ID: 14986243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults.
    Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW
    J Trop Pediatr; 1992 Feb; 38(1):17-21. PubMed ID: 1315397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory features and treatment of visceral leishmaniasis in hospitalized patients in Northwestern Ethiopia.
    Maru M
    Am J Trop Med Hyg; 1979 Jan; 28(1):15-8. PubMed ID: 219723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone.
    Seaman J; Pryce D; Sondorp HE; Moody A; Bryceson AD; Davidson RN
    J Infect Dis; 1993 Sep; 168(3):715-20. PubMed ID: 8394861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicoepidemiological study of drug resistance in Indian kala-azar.
    Sundar S; Thakur BB; Tandon AK; Agrawal NR; Mishra CP; Mahapatra TM; Singh VP
    BMJ; 1994 Jan; 308(6924):307. PubMed ID: 8124119
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
    el-Hassan AM; Meredith SE; Yagi HI; Khalil EA; Ghalib HW; Abbas K; Zijlstra EE; Kroon CC; Schoone GJ; Ismail A
    Trans R Soc Trop Med Hyg; 1995; 89(6):647-52. PubMed ID: 8594683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
    Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R
    Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya.
    Mueller YK; Kolaczinski JH; Koech T; Lokwang P; Riongoita M; Velilla E; Brooker SJ; Chappuis F
    Am J Trop Med Hyg; 2014 Jan; 90(1):33-39. PubMed ID: 24218406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indigenously acquired human visceral leishmaniasis in Al Agamy (Alexandria Governorate) Egypt.
    Faris R; Massoud A; Kassem S; Feinsod FM; el Said S; Youssef M; Amer M; Gadallah M; Saah AJ
    Ann Soc Belg Med Trop; 1986; 66(4):325-9. PubMed ID: 3032118
    [No Abstract]   [Full Text] [Related]  

  • 19. Kala-azar in a Scottish child.
    Kinmond S; Galea P; Simpson EM; Parida SK; Goel KM
    Lancet; 1989 Aug; 2(8658):325. PubMed ID: 2569117
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Indian kala-azar with pentavalent antimony.
    Arya SC
    Lancet; 1995 Mar; 345(8949):584. PubMed ID: 7776791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.